Neuraxis raises ~$5M through Series B Convertible Preferred Stock to three investors

Neuraxis, INC

Sold 2,100,840 shares of Series B Preferred Stock at $2.38 stated value for aggregate $5M, closed Nov 13, 2024.
Preferred ranks senior to common, convertible at any time into common shares; proceeds for working capital.
Registration rights require filing resale statement within 30 days; 1% monthly late penalty up to 6% of subscription amount, plus 18% interest if unpaid.
Investor board nominee Gil Aharon to join Board effective Jan 1, 2025, as long as investor holds ≥5% of outstanding shares.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.